K870931

Substantially Equivalent

TINA-QUANT(R) (A) C4

Applicant: Boehringer Mannheim Corp.
Product code: DBI
Advisory panel: Immunology
Date received: 1987-03-09
Decision date: 1987-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.